FIELD: medicine; veterinary.
SUBSTANCE: group of inventions can be used to produce a vaccine containing a live attenuated canine virus. For this purpose, the dry vaccine composition contains non-reducing oligosaccharides in amount of 30 % to 80 % (wt/wt), amino acid stabilizer from 5 % to 40 % (wt/wt), protein stabilizer from 2 % to 20 % (wt/wt), filler-stabilizer in amount of 2 % to 25 % (wt/wt). Amino acid stabilizer is arginine, the live attenuated virus is a live attenuated canine virus selected from a group, consisting of carnivore plague virus, adenovirus, parainfluenza virus and any combination thereof. Said dry composition is obtained in form of a flat cake, obtained on membrane or filter, dried in powder form by sublimation drying in beads, by spray drying or by spray drying with freezing. Group of inventions also relates to a method for preparing said vaccine.
EFFECT: use of this group of inventions enables using a given composition of the vaccine to obtain a dry composition of vaccines containing CDV, CAV2, CPV and CPI, stable at room temperature, as well as given composition can be used for viral vaccines, obtained by drying in form of flat cakes in bottles.
22 cl, 16 tbl
Title | Year | Author | Number |
---|---|---|---|
LIQUID STABLE VIRAL VACCINES | 2013 |
|
RU2641970C2 |
RECOVERING VIRUS RELATED TO CANINE PARVOVIRUS-2 FROM RACOON | 2010 |
|
RU2565538C2 |
METHOD FOR PRODUCING MEDICAMENT INCLUDING BIOLOGICALLY ACTIVE PROTEIN, AND FINAL PRODUCT | 2013 |
|
RU2663581C2 |
VACCINES WITH REDUCED FOAM FORMATION | 2015 |
|
RU2731534C2 |
ASSOCIATED VACCINE AGAINST CANINE DISTEMPER, PARVOVIRUS AND CORONAVIRUS ENTERITIS, ADENOVIRUS INFECTION OF DOGS | 2022 |
|
RU2806164C1 |
VACCINES BASED ON VIRUS-LIKE PARTICLES (VLP) OF CANINE PARVOVIRUS (CPV) AND APPLICATION THEREOF | 2016 |
|
RU2710854C1 |
ASSOCIATED VACCINE AGAINST DISTEMPER, PARVOVIRUS AND CORONAVIRUS ENTERITIS, ADENOVIRUS INFECTION AND CANINE RABIES | 2023 |
|
RU2817255C1 |
VACCINE AGAINST PLAGUE, ADENOVIRUS INFECTIONS, PARVOVIRUS AND CORONAVIRUS ENTERITIS, LEPTOSPIROSIS AND RABIES OF DOGS | 2013 |
|
RU2546247C2 |
ATTENUATED RECOMBINANT PARVOVIRUS APPLICABLE FOR DOG PROTECTION AGAINST PARVOVIRUS INFECTION | 2011 |
|
RU2527157C2 |
VACCINE WITH LIVE BACTERIAL ISOLATES FOR SYSTEMIC ADMINISTRATION | 2011 |
|
RU2593953C2 |
Authors
Dates
2021-01-21—Published
2014-09-26—Filed